Clinical trial
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
NCT06251492
Study timeline
Study start (actual)2024-01-30Date precision: day
Registry last updated2024-02-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancer Metastaticunresolved
Castration-resistant Prostate Cancerunresolved
Interventions
Stereotactic body radiotherapyRADIATION
AdebrelimabDRUG
Sponsors & collaborators
Fudan Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06251492 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.